Retatrutide appears to be a new medication in the fight against obesity. This revolutionary drug, categorized as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By activating https://haarisjlbq508060.dailyblogzz.com/36796839/tirzepatide-a-promising-new-treatment-for-obesity